RPG LifeScience.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE105J01010
  • NSEID: RPGLIFE
  • BSEID: 532983
INR
2,537.25
-63.9 (-2.46%)
BSENSE

Nov 20

BSE+NSE Vol: 6.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
211.64
195.69
176.89
180.03
181.68
168.92
143.09
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
211.64
195.69
176.89
180.03
181.68
168.92
143.09
Raw Material Cost
24.10
37.68
36.43
34.79
32.72
32.04
26.89
Purchase of Finished goods
58.72
39.53
22.63
43.63
38.78
33.06
21.22
(Increase) / Decrease In Stocks
-10.68
-9.06
1.53
-13.52
-4.92
-5.08
0.61
Employee Cost
44.09
37.76
36.30
35.32
36.16
33.70
31.60
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
54.99
46.19
47.17
40.05
39.91
39.73
37.28
Total Expenditure (Excl Depreciation)
171.22
152.10
144.06
140.27
142.65
133.45
117.60
Operating Profit (PBDIT) excl Other Income
40.42
43.59
32.83
39.76
39.03
35.47
25.49
Other Income
4.26
4.16
12.40
3.41
4.54
5.23
5.06
Operating Profit (PBDIT)
44.68
47.75
45.23
43.17
43.57
40.70
30.55
Interest
0.84
0.63
0.39
0.25
0.12
0.13
0.18
Exceptional Items
0.00
0.00
1.10
-8.42
11.22
0.00
109.90
Gross Profit (PBDT)
43.84
47.12
45.94
34.50
54.67
40.57
140.27
Depreciation
6.80
5.90
5.74
5.38
5.22
5.14
5.37
Profit Before Tax
37.04
41.22
40.20
29.12
49.45
35.43
134.90
Tax
8.82
10.64
10.30
6.99
12.60
9.14
17.55
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
28.22
30.58
29.90
22.13
36.85
26.29
117.35
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
28.22
30.58
29.90
22.13
36.85
26.29
117.35
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.62
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
26.60
30.58
29.90
22.13
36.85
26.29
117.35
Equity Capital
13.23
13.23
13.23
13.23
13.23
13.23
13.23
Face Value
8.0
8.0
8.0
8.0
8.0
8.0
8.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
16.08
18.49
18.08
13.38
22.28
15.9
70.96
Diluted Earnings per share
17.07
18.49
18.08
13.38
22.28
15.9
70.96
Operating Profit Margin (Excl OI)
19.1%
22.28%
18.56%
22.09%
21.48%
21.0%
17.81%
Gross Profit Margin
20.71%
24.08%
25.97%
19.16%
30.09%
24.02%
98.03%
PAT Margin
13.33%
15.63%
16.9%
12.29%
20.28%
15.56%
82.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is -1.18% vs 10.63% in Jun 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is -23.81% vs 2.24% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is -25.08% vs 32.58% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 23.81% vs 61.54% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of RPG LifeScience. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
211.64
288.27
-76.63
-26.58%
Other Operating Income
0.00
0.00
0.00
Total Operating income
211.64
288.27
-76.63
-26.58%
Raw Material Cost
24.10
156.92
-132.82
-84.64%
Purchase of Finished goods
58.72
14.60
44.12
302.19%
(Increase) / Decrease In Stocks
-10.68
-36.20
25.52
70.50%
Employee Cost
44.09
45.43
-1.34
-2.95%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
54.99
59.03
-4.04
-6.84%
Total Expenditure (Excl Depreciation)
171.22
239.78
-68.56
-28.59%
Operating Profit (PBDIT) excl Other Income
40.42
48.49
-8.07
-16.64%
Other Income
4.26
1.12
3.14
280.36%
Operating Profit (PBDIT)
44.68
49.61
-4.93
-9.94%
Interest
0.84
10.44
-9.60
-91.95%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
43.84
39.17
4.67
11.92%
Depreciation
6.80
7.73
-0.93
-12.03%
Profit Before Tax
37.04
31.45
5.59
17.77%
Tax
8.82
7.98
0.84
10.53%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
28.22
23.47
4.75
20.24%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
28.22
23.47
4.75
20.24%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
1.62
0.00
1.62
Other related items
0.00
0.00
0.00
Consolidated Net Profit
26.60
23.47
3.13
13.34%
Equity Capital
13.23
10.03
3.20
31.90%
Face Value
8.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
16.08
2.34
13.74
587.18%
Diluted Earnings per share
17.07
2.34
14.73
629.49%
Operating Profit Margin (Excl OI)
19.10%
16.82%
0.00
2.28%
Gross Profit Margin
20.71%
13.59%
0.00
7.12%
PAT Margin
13.33%
8.14%
0.00
5.19%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 193.39 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -1.18% vs 10.63% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 6.45% vs 5.50% in Sep 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 23.29 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -23.81% vs 2.24% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -36.80% vs 777.38% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.65 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -25.08% vs 32.58% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -16.35% vs -15.02% in Sep 2025

Quarterly - Interest
Interest 0.78 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 23.81% vs 61.54% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 550.00% vs -29.41% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.88%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025